Related Experiment Video
Updated: Feb 6, 2026

Analysis of Human Natural Killer Cell Metabolism
Published on: June 22, 2020
Frequent Mutations in Natural Killer/T Cell Lymphoma
Abstract:
Extranodal natural killer (NK)/T cell lymphoma (ENKTL-NT or NKTCL), with its aggressive nature and poor prognosis, has been widely studied to discover more effective treatment options. Various somatic gene alterations have been identified by traditional Sanger sequencing. However, recently, novel gene mutations in NKTCL have been revealed by next-generation sequencing (NGS) technology, suggesting the potential for novel targeted therapies. This review discusses recurrent aberrations in NKTCL detected by NGS, which can be categorized into three main groups, specifically, tumor suppressors (TP53, DDX3X, and MGA), the JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, and EP300). Some epigenetic dysregulation and DDX3X mutation, which have been rarely identified by traditional sequencing technology, were recently uncovered with high frequencies by NGS. In this review, we summarize the mutational frequencies of various genes in NKTCL. In general, based on our analysis, BCOR is the most frequently mutated gene (16.9%), followed by TP53 (14.7%), and DDX3X (13.6%). The characterization of such genes provides new insight into the pathogenesis of this disease and indicates new biomarkers or therapeutic targets.
Insights
Next-generation sequencing (NGS) identified novel gene mutations in extranodal natural killer (NK)/T cell lymphoma (ENKTL). BCOR, TP53, and DDX3X are frequently mutated, offering potential therapeutic targets for this aggressive cancer.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Extranodal natural killer (NK)/T cell lymphoma (ENKTL) is an aggressive malignancy with a poor prognosis.
- Traditional Sanger sequencing has identified some somatic gene alterations in ENKTL.
- Novel targeted therapies are needed due to the limited efficacy of current treatments.
Purpose of the Study:
- To review recurrent genetic aberrations in ENKTL detected by next-generation sequencing (NGS).
- To identify frequently mutated genes and their potential as therapeutic targets or biomarkers.
Main Methods:
- Review of studies utilizing next-generation sequencing (NGS) to analyze genetic alterations in ENKTL.
- Categorization of identified mutations into tumor suppressors, JAK/STAT cascade, and epigenetic modifiers.
- Analysis of mutational frequencies of various genes.
Main Results:
- NGS revealed novel gene mutations in ENKTL, including epigenetic dysregulation and DDX3X mutations, often missed by traditional methods.
- Recurrent aberrations were categorized into tumor suppressors (TP53, DDX3X, MGA), JAK/STAT cascade, and epigenetic modifiers (KMT2D, BCOR, ARID1A, EP300).
- BCOR (16.9%), TP53 (14.7%), and DDX3X (13.6%) were the most frequently mutated genes.
Conclusions:
- NGS technology has significantly advanced the understanding of ENKTL pathogenesis by uncovering high-frequency mutations.
- Identified genetic aberrations provide new insights into disease mechanisms.
- These findings highlight potential novel biomarkers and therapeutic targets for ENKTL.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
What is Natural Selection?
Mutation, Gene Flow, and Genetic Drift
Viral Mutations
Nature and Nurture

